1700.00GBp-1.29%Mkt Cap: 88.82M GBpP/E: 12.06Last update: 2026-05-13
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertilit…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)12.06
P/E (Forward)0.09
PEG—
P/B8.05
P/S7.08
EV/EBITDA8.49
EV/Revenue6.66
EPS (TTM)1.41
EPS (Forward)179.30
Cash Flow & Leverage
FCF Yield7.43%
FCF Margin52.59%
Operating CF7.03M GBp
CapEx (TTM)19.19K GBp
Net Debt/EBITDA-0.54
Net Debt-5.30M GBp
Technical
SMA 501632.80 (+4.1%)
SMA 2001951.97 (-12.9%)
Beta0.56
S&P 52W Chg24.23%
Avg Vol (30d)13.51K
Avg Vol (10d)8.32K
Technical Indicators
RSI (14)48.4
MACD6.6617
MACD Signal17.9482
MACD Hist.-11.2865
BB Upper1814.99 GBp
BB Middle1721.95 GBp
BB Lower1628.91 GBp
BB Width10.81%
ATR (14)106.52 GBp
Vol Ratio (20d)1.04x
52W Range
1300.0023% of range3020.00
52W High3020.00 GBp
52W Low1300.00 GBp
Profitability
Gross Margin90.86%
EBITDA Margin78.45%
Profit Margin57.83%
Oper. Margin76.56%
ROE65.66%
ROA58.96%
Revenue Growth-8.50%
Earnings Growth-3.90%
Balance Sheet
Debt/Equity—
Current Ratio6.12
Quick Ratio5.76
Book Value/Sh2.113 GBp
Cash/Share1.015 GBp
Dividends
Fwd Div Rate1.500 GBp
Trail. Div Rate1.500 GBp
Div. Yield8.82%
5Y Avg Yield4.35%
Payout Ratio106.75%
Ex-Div DateApr 9, 2026
Pay Date—
Ownership
Shares Out.5.22M
Float4.14M
Insiders7.77%
Institutions65.37%
Analyst Consensus
Rating—
Target (Mean)3900.00 GBp
Target Range3900.00 GBp – 3900.00 GBp
# Analysts1
Company
Market Cap88.82M GBp
Enterprise Value83.52M GBp
Revenue (TTM)12.54M GBp
Gross Profit11.92M GBp
Net Income (TTM)7.58M GBp
Revenue/Share2.401 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees12
Last Price1700.00 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—